{
    "2020-11-24": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报：板块持续回调，逢低布局景气度高的细分赛道",
                "features": {
                    "keywords": [
                        "医药生物",
                        "板块回调",
                        "逢低布局",
                        "景气度高",
                        "细分赛道"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "320亿主力资金近三日撤出全A(等权)概念股",
                "features": {
                    "keywords": [
                        "主力资金",
                        "撤出",
                        "全A",
                        "概念股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业双周报",
                "features": {
                    "keywords": [
                        "医药生物",
                        "双周报"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "创新药行业周报：贝达药业ALK抑制剂恩沙替尼获批",
                "features": {
                    "keywords": [
                        "创新药",
                        "贝达药业",
                        "ALK抑制剂",
                        "恩沙替尼",
                        "获批"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物",
                        "创新药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}